Indeed, type-1 IFN release by pDC upon CpG binding may induce PD-L1 expression in both tumor and immune cells; additionally, T cells that are recruited to and are activated in the tumor microenvironment may induce PD-L1 expression through IFNγ release. Here, IFNG is linked to neoplasm.